Miller Aine (CIK 0002012524)

Latest company ownership

TBPH - Theravance Biopharma, Inc.

Role: SVP, DEV & HEAD OF IRE OFFICE

Shares held

201,012

Last filed at

Nov 24, 2025

Confidence Score

43.6

2025Q4

Confidence Score History

2024Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Nov 20, 2025	Nov 24, 2025	Theravance Biopharma, Inc.	SVP, DEV & HEAD OF IRE OFFICE	Sell	42.5	-6,989	-3.36%	✗	$125.1K
Aug 20, 2025	Aug 22, 2025	Theravance Biopharma, Inc.	SVP, DEV & HEAD OF IRE OFFICE	Sell	42.5	-6,989	-3.25%	✗	$93.6K
May 19, 2025	May 21, 2025	Theravance Biopharma, Inc.	SVP, DEV & HEAD OF IRE OFFICE	Sell	65.0	+729	0.34%	✗	$91.7K
Feb 20, 2025	Feb 24, 2025	Theravance Biopharma, Inc.	SVP, DEV & HEAD OF IRE OFFICE	Sell	42.5	-11,295	-7.50%	✗	$109.1K
Nov 20, 2024	Nov 22, 2024	Theravance Biopharma, Inc.	SVP, DEV & HEAD OF IRE OFFICE	Sell	42.5	-10,076	-6.27%	✗	$100.5K
Aug 20, 2024	Aug 22, 2024	Theravance Biopharma, Inc.	SVP, DEV & HEAD OF IRE OFFICE	Sell	46.3	-5,201	-3.14%	✗	$42.8K
May 20, 2024	May 22, 2024	Theravance Biopharma, Inc.	SVP, DEV & HEAD OF IRE OFFICE	Sell	46.3	-5,201	-3.04%	✗	$47.3K
Feb 20, 2024	Feb 22, 2024	Theravance Biopharma, Inc.	SVP, DEV & HEAD OF IRE OFFICE	Sell	42.5	-11,782	-8.11%	✗	$105.1K